- Citations, last 5 years
- 425
- Works, last 5 years
- 8
- h-index
- 29
- Scientists listed
- 0
- Grants since 2016
- 5
Grants received
2025–2028 · grant · PRMRP
A Phase 2 Clinical Trial of SRX246 in Fragile X Syndrome (FXS)
Michael Brownstein · Azevan Pharmaceuticals (United States) · funded by Congressionally Directed Medical Research Programs
2024–2026 · grant · PRMRP
A New Drug to Prevent the Effects of Mild TBI/Concussion
Neal Simon · Azevan Pharmaceuticals (United States) · funded by Congressionally Directed Medical Research Programs
2019–2021 · research · R43
A New Drug for the Treatment of Traumatic Brain Injury
Michael J Brownstein · Azevan Pharmaceuticals (United States) · funded by National Institutes of Health
2015–2020 · grant · PH-TBI
A POC Clinical Trial for PTSD with a First-In-Class Vasopressin 1a Receptor Antagonist
Neal Simon · Azevan Pharmaceuticals (United States) · funded by Congressionally Directed Medical Research Programs
2015–2023 · research · R44
Advancing SRX246 to Commericialization
Michael J Brownstein · Azevan Pharmaceuticals (United States) · funded by National Institutes of Health